Strong evidence suggests that the UCP2 gene polymorphisms may affect the expression/activity levels of UCP2 and subsequently affect related biological processes, which finally result in a variety of diseases, including metabolic diseases and cancer12. This evidence concerns the gene UCP2 and Other metabolic disease.